Armata Pharmaceuticals (ARMP) Enterprise Value (2016 - 2018)
Historic Enterprise Value for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to -$13.4 million.
- Armata Pharmaceuticals' Enterprise Value fell 7337.22% to -$13.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$13.4 million, marking a year-over-year decrease of 7337.22%. This contributed to the annual value of -$5.1 million for FY2017, which is 0.0% changed from last year.
- Latest data reveals that Armata Pharmaceuticals reported Enterprise Value of -$13.4 million as of Q3 2018, which was down 7337.22% from -$15.4 million recorded in Q2 2018.
- In the past 5 years, Armata Pharmaceuticals' Enterprise Value registered a high of -$2.2 million during Q1 2017, and its lowest value of -$16.6 million during Q1 2015.
- Moreover, its 5-year median value for Enterprise Value was -$9.0 million (2017), whereas its average is -$9.5 million.
- Within the past 5 years, the most significant YoY rise in Armata Pharmaceuticals' Enterprise Value was 6766.89% (2014), while the steepest drop was 218581.36% (2014).
- Over the past 5 years, Armata Pharmaceuticals' Enterprise Value (Quarter) stood at -$6.6 million in 2014, then crashed by 42.38% to -$9.4 million in 2015, then surged by 45.23% to -$5.1 million in 2016, then changed by 0.0% to -$5.1 million in 2017, then plummeted by 160.97% to -$13.4 million in 2018.
- Its Enterprise Value was -$13.4 million in Q3 2018, compared to -$15.4 million in Q2 2018 and -$8.2 million in Q1 2018.